Venture Capital Warms to European Biotechs
The U.S. IPO boom offers a route for some, as some biotechs in Switzerland have attracted about $80 million in VC funding so far this year
12 August 2013•4 mins read
The U.S. IPO boom offers a route for some, as some biotechs in Switzerland have attracted about $80 million in VC funding so far this year
